EVT Execute
Target identification and validation
Hit identification
Sample management
Chemistry
DMPK and ADME-Tox
Research informatics and in silico drug discovery
Proteomics and metabolomics
Bio-reagents
In vitro biology
In vivo pharmacology
Biomarkers
Antibody discovery
Drug discovery services
Just - Evotec Biologics
Evotec GT
Biologics
INDiGO
API capabilities
Material sciences
Analytical development and Quality Control
Pre-clinical formulation
DP Development & Manufacturing
Integrated CMC
Safety assessment
Pathology
Bioanalysis
ADME
Abuse liability assessment
Integrated pre-clinical development
Anti-infectives
Immunology and inflammation
Metabolic diseases and complications
Neurosciences
Oncology
Respiratory
Therapeutic areas
Integrated drug discovery
EVT Execute alliances
Scientific publications
Resources
Business Development Events
Science pool
EVT Innovate
Pipeline of product opportunities
Pharma partnerships
R&D projects
iPSC platform
Spin-offs and other holdings
BRIDGEs
DDup
Career
Invest
Stock information
News
Financial publications
IR Events
Annual General Meeting Archive
Annual General Meeting
Corporate Governance
About
Evotec worldwide
History
Management
Supervisory Board
Imprint
This is a result
This is a result
This is a result
This is a result
This is a result
This is a result
DE
EN
dbAccess Berlin Conference 2019
Downloads
Investor presentation
PDF, 1.6 MB
TOP